Camrelizumab Combined With Radiotherapy for Adjuvant Treatment of Esophageal Squamous Cell Carcinoma After Surgery
Clinical trial NCT04741490 · UNKNOWN
Trial details
- NCT number
- NCT04741490
- Sponsor
- Fuzhou General Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2022-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.